IP Library Granted Patent US 10,941,154
Granted Patent B2
US 10,941,154 · App. 16/622,352 · Granted Mar 9, 2021

Hydrogenation process for preparing oxycodone hydrochloride from 14-hydroxycodeinone

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,941,154
App. No.
16/622,352
Granted
Mar 9, 2021
Kind
B2
Abstract

A process for preparing oxycodone hydrochloride, said process comprising hydrogenating 14-hydroxycodeinone in an alcoholic solvent and hydrochloric acid to form oxycodone hydrochloride, wherein (a) the hydrogenation is carried out in the presence of a heterogeneous platinum group metal (PGM) catalyst and hydrogen gas, (b) the hydrogenation is carried out at one or more temperatures greater than ambient temperature in the presence of a hydrogenation catalyst and hydrogen gas, wherein the solution of 14-hydroxycodeinone and hydrochloric acid is heated to temperature before it is exposed to the hydrogen gas, (c) the oxycodone hydrochloride comprises 6a-oxycodol in an amount <about 0.300 area % as determined by HPLC, characterized in that (d) the pH of the solution of 14-hydroxycodeinone and hydrochloric acid is in the range of about ≥2.5 to about ≤4.5; (e) the process is carried out in one pot, and (f) the oxycodone hydrochloride precipitates out of the solution.

Claims (20)

1. A process for preparing oxycodone hydrochloride, said process comprising hydrogenating 14-hydroxycodeinone in an alcoholic solvent and hydrochloric acid to form oxycodone hydrochloride, wherein

(a) the hydrogenation is carried out in the presence of a heterogeneous platinum group metal (PGM) hydrogenation catalyst and hydrogen gas,

(b) the hydrogenation is carried out at one or more temperatures greater than ambient temperature, wherein the 14-hydroxycodeinone in an alcoholic solvent and hydrochloric acid is heated to temperature before it is exposed to the hydrogen gas,

(c) the pH of the 14-hydroxycodeinone in an alcoholic solvent and hydrochloric acid is in the range of about ≥2.5 to about ≤4.5,

(d) the process is carried out in one pot; and

(e) the oxycodone hydrochloride comprises 6α-oxycodol in an amount <0.300 area % as determined by HPLC.

2. The process according to claim 1 , wherein the oxycodone hydrochloride substantially precipitates out of solution when the process for preparing oxycodone hydrochloride is carried out in the range of ≥about 30° C. to about ≤about 45° C.

3. The process according to claim 1 , wherein the oxycodone hydrochloride is substantially dissolved when the process is carried out in the range of ≥about 45° C. to about ≤about 85° C.

4. The process according to claim 1 , wherein the alcoholic solvent is selected from the group consisting of methanol, ethanol, n-propanol, and isopropanol or mixtures thereof.

5. The process according to claim 4 , wherein the alcoholic solvent is ethanol.

6. The process according to claim 1 , wherein the hydrogen gas pressure is between about 30-55 psi.

7. The process according to claim 6 , wherein the hydrogen gas pressure is about 40 psi±5 psi.

8. The process according to claim 1 , wherein the one or more temperatures greater than ambient temperature are in the range of ≥about 30° C. to about ≤about 85° C.

9. The process according to claim 8 , wherein the one or more temperatures greater than ambient temperature are in the range of ≥about 30° C. to about ≤50° C.

10. The process according to claim 9 , wherein the one or more temperatures greater than ambient temperature is about 40° C.

11. The process according to claim 1 , wherein the pH is in the range of about ≥3.0 to about ≤4.0.

12. The process according to claim 1 , wherein the heterogeneous platinum group metal hydrogenation catalyst is Pd/C.

13. The process according to claim 1 , wherein the oxycodone hydrochloride comprises 6α-oxycodol in an amount ≤about 0.100 area % as determined by HPLC.

14. The process according to claim 1 , wherein the oxycodone hydrochloride comprises ≤about 25 ppm of an α,β-unsaturated ketone.

15. The process according to claim 14 , wherein the oxycodone hydrochloride comprises ≤about 10 ppm of an α,β-unsaturated ketone.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2022
From: JOHNSON MATTHEY PUBLIC LIMITED COMPANY
To: MACFARLAN SMITH LIMITED
Reel/Frame 061888/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2021
From: GAUVREAU, PAUL
To: JOHNSON MATTHEY PUBLIC LIMITED COMPANY
Reel/Frame 055072/0394 →